GDRX GoodRx Holdings

GoodRx to Present Virtually at Upcoming Investor Conferences

GoodRx to Present Virtually at Upcoming Investor Conferences

SANTA MONICA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced that executives from the Company will be presenting at the following virtual investor conferences:

  • Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time)
  • Citi 2021 Global Technology Virtual Conference on Tuesday, September 14, at 9:10 a.m. Pacific Time (12:10 p.m. Eastern Time)
  • Goldman Sachs 30th Annual Communacopia Conference on Wednesday, September 22, at 11:55 a.m. Pacific Time (2:55 p.m. Eastern Time)

Live webcasts of all presentations and any accompanying presentation materials, as well as the archived recordings, will be available on the Company's Investor Relations website, . Following each conference, archived recordings will be available on the Company’s website for at least 30 days.

About GoodRx

GoodRx helps Americans get the healthcare they need at a price they can afford. As America’s leading resource for healthcare savings, GoodRx connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests. We have helped Americans save over $30 billion since 2011 and we are one of the most downloaded medical apps over the past decade.

Investor Contact

GoodRx

Whitney Notaro

Press Contact

GoodRx

Lauren Casparis



EN
26/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GoodRx Holdings

GoodRx, Inc.: Update to credit analysis following refinancing

Our credit view of this issuer reflects its moderate financial leverage on a gross basis, constrained by its high dependence on PBM operating model.

Moody's Ratings affirms GoodRx's B1 CFR, assigns B1 rating to proposed...

Moody's Ratings (Moody's) affirmed the ratings of GoodRx, Inc. ("GoodRx"), including its B1 Corporate Family Rating ("CFR"), B1-PD Probability of Default Rating ("PDR"), and B1 rating on the backed senior secured first lien revolving credit facility. Concurrently, Moody's assigned a B1 rating to Goo...

GoodRx, Inc.: Update to credit analysis following refinancing of capit...

Our credit view of this issuer reflects its moderate financial leverage on a gross basis, constrained by its high dependence on PBM operating model.

Moody's affirms GoodRx's B1 CFR, assigns B1 rating to new bank credit ...

Moody's Investors Service (Moody's) affirmed the ratings of GoodRx, Inc. ("GoodRx"), including the B1 Corporate Family Rating (CFR) and B1-PD Probability of Default Rating (PDR). Concurrently, Moody's assigned a B1 rating to the new 7-year backed senior secured first lien term loan B and to the newl...

GoodRx, Inc.: Update to credit analysis

Our credit view of this issuer reflects its moderate financial leverage on a gross basis, constrained by its high dependence on PBM operating model.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch